We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

    Purpose of Review

    To summarize evidence on the potential involvement of the osteoprotegerin (OPG)/receptor activator of nuclear factor-kappa B (NF-κΒ)...

    Ilias D. Vachliotis, Stergios A. Polyzos in Current Obesity Reports
    Article Open access 19 May 2023
  2. LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort

    Summary

    Soluble RANKL (sRANKL) and osteoprotegerin (OPG) are regulators of osteoclast differentiation and activation, but adequate pediatric reference...

    Helene Tietze, Veronika Pott, ... Maren Leifheit-Nestler in Osteoporosis International
    Article Open access 09 November 2023
  3. Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling

    Cancer cell plasticity plays a crucial role in tumor initiation, progression, and metastasis and is implicated in the multiple cancer defense...

    Peter Kubatka, Lenka Koklesova, ... Mehdi Shakibaei in Cancer and Metastasis Reviews
    Article Open access 04 October 2023
  4. Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial

    Summary

    We investigated whether the drug denosumab modulates the inflammatory response after total hip arthroplasty in a randomized controlled trial....

    C. Sköld, K. Kultima, ... H. Mallmin in Osteoporosis International
    Article Open access 24 May 2022
  5. Exogenous interleukin-1 beta stimulation regulates equine tenocyte function and gene expression in three-dimensional culture which can be rescued by pharmacological inhibition of interleukin 1 receptor, but not nuclear factor kappa B, signaling

    We investigated how Interleukin 1 beta (IL-1β) impacts equine tenocyte function and global gene expression in vitro and determined if these effects...

    Ross Eric Beaumont, Emily Josephine Smith, ... Deborah Jane Guest in Molecular and Cellular Biochemistry
    Article Open access 14 June 2023
  6. Alpha-pinene modulates inflammatory response and protects against brain ischemia via inducible nitric oxide synthase-nuclear factor–kappa B-cyclooxygenase-2 pathway

    Backgrounds

    Cerebral ischemia-reperfusion leads to brain tissue injury. Inflammation and apoptosis play pivotal roles in the pathology.

    ...
    Mohammad Shabani, Sohaila Erfani, ... Seyedeh Mahdieh Khoshnazar in Molecular Biology Reports
    Article 17 June 2023
  7. Changes in expression of nuclear factor kappa B subunits in the ovine thymus during early pregnancy

    There is a pregnant maternal immunological tolerance that protects the fetus and promotes its growth, and nuclear factor kappa B (NF-κB) family...

    Ling Yang, Chunjiang Cai, ... Leying Zhang in Scientific Reports
    Article Open access 21 October 2022
  8. Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1

    Sepsis, a life-threatening condition characterized by dysregulated immune responses, remains a significant clinical challenge. Myricanol, a natural...

    Kaiyuan Liu, Liuye Yang, ... Minglu Liang in Inflammopharmacology
    Article 25 March 2024
  9. Expression of nuclear factor kappa B in ovine maternal inguinal lymph nodes during early pregnancy

    Background

    Pregnancy-induced immunological changes contribute to the maternal immune tolerance. Nuclear factor kappa B (NF-κB) pathway participates in...

    Leying Zhang, Taipeng Zhang, ... Ling Yang in BMC Veterinary Research
    Article Open access 11 July 2022
  10. Neuroinflammation in schizophrenia: the role of nuclear factor kappa B

    Neuroinflammation, particularly in the dorsolateral prefrontal cortex, is well-established in a subset of people with schizophrenia, with significant...

    Caitlin E. Murphy, Adam K. Walker, Cynthia Shannon Weickert in Translational Psychiatry
    Article Open access 14 October 2021
  11. Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling

    Background

    MicroRNAs (miRNAs) play crucial roles in the development of hepatocellular carcinoma (HCC). Hsa-microRNA-27b-3p ( hsa-miR-27b ) is involved...

    **gyuan Wen, Zhao Huang, ... Bixiang Zhang in Cellular & Molecular Biology Letters
    Article Open access 23 September 2022
  12. Do anti-carbamylated protein antibodies in rheumatoid arthritis reflect local and systemic osteoporosis? A study of osteoprotegrin and receptor activator for nuclear factor kappa B ligand and radiological assessment

    Background

    One of the most important and dangerous complications of rheumatoid arthritis (RA) is bone loss, which manifested by erosions and...

    Manal Shawky Hussein, Rasha Ahmed Gaber, ... Elsayed Mohamed Rageh in Egyptian Rheumatology and Rehabilitation
    Article Open access 23 March 2021
  13. A case of minimal change disease after the administration of anti receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal antibody: a case report

    Background

    Minimal change disease (MCD) is one of the causes of idiopathic nephrotic syndrome in adults. The pathogenesis of proteinuria in MCD has...

    Keisuke Horikoshi, Norihiko Sakai, ... Takashi Wada in BMC Nephrology
    Article Open access 29 September 2020
  14. E1231 Alleviates Diabetic Cardiomyopathy by Regulating the Silent Information Regulator 1/Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α/Nuclear Factor Erythroid 2-Related Factor 2 Pathway

    We aimed to investigate the underlying function and mechanism of E1231 against diabetic cardiomyopathy (DCM). H9c2 cells were exposed to either 33...

    Yunxia Cui, Hongjun Lou, ... ** Gao in Pharmaceutical Chemistry Journal
    Article 01 May 2024
  15. NF-kappa B signaling pathway is associated with metformin resistance in type 2 diabetes patients

    Introduction

    Metformin is an essential medicine that is most widely prescribed frontline for the treatment of Type 2 diabetes (T2D). Metformin...

    Vahid Mansouri, Fatemeh Bandarian, ... Mostafa Rezaei-Tavirani in Journal of Diabetes & Metabolic Disorders
    Article 06 July 2024
  16. Targeting Nuclear Factor-Kappa B Signaling Pathway by Curcumin: Implications for the Treatment of Multiple Sclerosis

    Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system, which involves an auto-immune mechanism that leads to...
    Meysam Gachpazan, Sadra Habbibirad, ... Amirhossein Sahebkar in Studies on Biomarkers and New Targets in Aging Research in Iran
    Chapter 2021
  17. NF-κB subunits direct kinetically distinct transcriptional cascades in antigen receptor-activated B cells

    The nuclear factor kappa B (NF-κB) family of transcription factors orchestrates signal-induced gene expression in diverse cell types. Cellular...

    Mingming Zhao, Prashant Chauhan, ... Ranjan Sen in Nature Immunology
    Article Open access 31 July 2023
  18. The effect of low-level laser radiation and doxycycline on the levels of osteoprotegerin and receptor activator of nuclear factor kappa-B ligand

    The present in vitro study was conducted to investigate the effect of low-level laser (LLL) radiation and doxycycline on the levels of...

    Shirin Zahra Farhad, Amir Siadat, ... Amir Saberi-Demneh in Lasers in Medical Science
    Article 27 March 2020
  19. Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry

    The pathophysiology of psoriasis is complex and has not been completely elucidated. Better understanding of the pathogenesis may contribute to...

    **ran Lin, **anmin Meng, ... **grong Lin in Molecular and Cellular Biochemistry
    Article 29 March 2022
  20. SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway

    Coronavirus disease 2019 (COVID-19) is a recent pandemic caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) leading to...

    Rabab S. Hamad, Hayder M. Al-kuraishy, ... Gaber El-Saber Batiha in Cell Stress and Chaperones
    Article Open access 05 October 2023
Did you find what you were looking for? Share feedback.